Search hospitals > District of Columbia > Washington
Sibley Memorial Hospital
Claim this profileWashington, District of Columbia 20016
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Prostatic Neoplasm
217 reported clinical trials
32 medical researchers
Summary
Sibley Memorial Hospital is a medical facility located in Washington, District of Columbia. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Prostatic Neoplasm and other specialties. Sibley Memorial Hospital is involved with conducting 217 clinical trials across 351 conditions. There are 32 research doctors associated with this hospital, such as Nilofer S. Azad, Michael J. Pishvaian, Channing Paller, MD, and Cesar A. Santa-Maria.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
Top PIs
Nilofer S. AzadJohns Hopkins University/Sidney Kimmel Cancer Center7 years of reported clinical research
Studies Bile Duct Cancer
Studies Cancer
15 reported clinical trials
29 drugs studied
Michael J. PishvaianSibley Memorial Hospital4 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
17 reported clinical trials
37 drugs studied
Channing Paller, MDSibley Memorial Hospital2 years of reported clinical research
Expert in Prostate Cancer
Studies Prostatic Neoplasm
12 reported clinical trials
24 drugs studied
Cesar A. Santa-MariaJohns Hopkins University8 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
12 reported clinical trials
30 drugs studied
Clinical Trials running at Sibley Memorial Hospital
Breast Cancer
Pancreatic Cancer
Bladder Cancer
Parotid Gland Cancer
Skin Cancer
Lung Cancer
Merkel Cell Carcinoma
Cancer
Non-Small Cell Lung Cancer
Breast cancer
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sibley Memorial Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.